International Clinical Trial: A non-interventional, real-world study on the adjuvant treatment of Chinese EGFR-positive stage IA NSCLC patients with high-risk factors using third-generation EGFR-TKIs

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127214) titled 'A non-interventional, real-world study on the adjuvant treatment of Chinese EGFR-positive stage IA NSCLC patients with high-risk factors using third-generation EGFR-TKIs' on June 26.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Affiliated Hospital of Guangxi Medical University

Condition: Histopathologically confirmed EGFR mutation-positive stage Ia non-small cell lung cancer (NSCLC) with high-risk factors

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-01

Target Sample Size: Three-generation EGFR-TKI adjuvant therapy for Chinese ...